Company Culture
Applied Digital champions a proactive approach to workplace safety, empowering employees to take ownership of their health and safety. This video showcases our open-door policy, which allows employees to easily connect with environmental health and safety (EH&S) professionals via phone, email, or a dedicated helpline for support in any situation. We also highlight our…
Latest
Applied Digital
Applied Digital’s Executive Leadership Commitment to Safety
This video explores the profound impact of Applied Digital’s executive leadership view commitment to safety. It highlights the key initiatives led by senior executives to foster a culture where safety is paramount. A standout strategy is the incorporation of a ‘safety moment’ at the start of every meeting, designed to heighten safety awareness from…
Applied Digital
At Applied Digital, Employee Safety is #1
At Applied Digital, employee safety transcends mere compliance—it’s a core value that defines our corporate ethos. This video underlines the importance of creating a robust health and safety environment, ensuring every team member returns home safely daily, and fostering a positive and secure workplace atmosphere. By prioritizing safety above all, including production, Applied Digital…
Applied Digital
Applied Digital on the Move
This video follows the major accomplishments of Applied Digital from their IPO in Apr 2022 until October of 2023. It includes major announcements like – Partnerships with NVidia, Supermicro and Hewlett Packard – Opening new facilities in North Dakota – Gaining and onboarding new Cloud clients – Initiation of a Cloud AI service
Applied Digital
Who is Applied Digital?
Applied Digital is a U.S. based provider of next-generation digital infrastructure, redefining how digital leaders scale high-performance compute (HPC). With dedicated and experienced leadership in the fields of power procurement, engineering, and construction, Applied Digital collaborates with local utilities to solve the problem of congestion on the power grid while stimulating the development of more…
Applied Digital
Wes Cummins on Applied Digital’s Promising Horizon
Wes Cummins,CEO of Applied Digital, shares his enthusiasm for Applied Digital’s future, emphasizing the development of a robust HPC strategy. With their first facility successfully operational in Jamestown and plans to expand further in Ellendale and other yet-to-be-announced locations, he is confident that the company’s future achievements will eclipse its impressive past.
Applied Digital
Applied Digital: From ‘What Ifs’ to Tangible Innovation
Applied Digital envisions a future where high-performance computing data centers aren’t just functional but transformative. With meticulously designed digital infrastructure, they aim to cultivate an environment ripe for innovation. In their perspective, every element, from airflows to dynamic server configurations, are potential drivers of change. In the fast-paced digital age, Applied Digital positions itself as…
Latest
Analyzing the Suppressive TME in In Vitro Based Assays
In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…
Targeting T Cells Within the Cancer Immunity Cycle
As cancer immunotherapy continues to reshape treatment landscapes, fine-tuning T-cell responses has become a critical frontier. Recent advances in 3D organoid models and high-content imaging are enabling scientists to closely mimic patient-specific tumor environments—unlocking insights into how T cells behave, respond, and falter under immune checkpoint blockade. With over 4,000 immune modulators in clinical…
Advanced In Vitro Technologies to Investigate Therapeutic Impact on the Cancer Immunity Cycle
As immunotherapy revolutionizes cancer treatment, the need for physiologically relevant preclinical models becomes more urgent than ever. Despite the success of immune checkpoint inhibitors, a large majority of patients fail to achieve long-lasting responses, prompting researchers to explore more complex and predictive assays. The cancer immunity cycle, first described in 2013, remains a central framework…
Inside Oncology Drug Development: Overcoming Resistance with Science
In the last two decades, oncology has undergone a transformation with over 300 new cancer therapies approved by the FDA—many offering novel mechanisms of action. Despite these innovations, resistance to treatment remains a critical challenge, with cancer cells evolving or adapting to evade even the most advanced therapeutics. This issue is particularly pressing given that…
